According to the latest report by IMARC Group “Blood Culture Test Market Size: Global Industry Trends, Share, Growth, Opportunity and Forecast 2021-2026“, The global blood culture test market reached a value of US$ 4.2 Billion in 2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 9% during 2021-2026.
A blood culture test is used to check foreign invaders like yeast, bacteria, and other microorganisms in the blood. It relies on the blood sample of an individual obtained via sterile technique, which is kept in culture media and incubated in a controlled environment for a few days. the results help in determining the pathogens causing the infection and possible methods for combating the disease.
The global market is primarily driven by the rising incidences of bloodstream infections (BSI), sepsis and environment-borne diseases. Besides this, the increasing prevalence of chronic diseases, especially among the geriatric population, which is relatively more prone to medical ailments, is also contributing to the market growth. Furthermore, leading players are focusing on launching novel diagnostic techniques to reduce diagnosis time, eliminate manual errors and offer early prevention of infections. This, along with the rising cases of coronavirus disease (COVID-19), is escalating the demand for blood culture tests, thereby supporting the market growth.
Request for a free sample copy of this report: https://www.imarcgroup.com/blood-culture-test-market/requestsample
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
Some of these key players include:
- Abbott Laboratories (ABT)
- Beckman Coulter ( BEC )
- BD (Becton, Dickinson and Company) (NYSE:BDX)
- BIOMERIEUX (BIM.PA)
- Bruker Corporation (BRKR)
- Cepheid (NASDAQ:CPHD). (Danaher Corporation)
- Luminex Corporation
- Merck Group
- Siemens Healthineers AG
- Roche Diagnostics
- T2 Biosystems, Inc. (TTOO)
- Thermo Fisher Scientific Inc. (NYSE: TMO)
Explore full report with table of contents: https://www.imarcgroup.com/blood-culture-test-market
The report has segmented the market on the basis of Product Type, End-User and Region.
Breakup by Testing Method:
Breakup by Product:
- Blood Culture Media
- Aerobic Blood Culture Media
- Anaerobic Blood Culture Media
- Fungi/Yeast Blood Culture Media
- Mycobacteria Blood Culture Media
- Assay Kits and Reagents
- Blood Culture Accessories
- Blood Culture Media
- Automated Blood Culture Systems
- Supporting Laboratory Equipment
- Colony Counters
- Gram Stainers
- Software and Services
Breakup by Technology:
- Culture-based Technology
- Molecular Technology
- Proteomic Technology
Breakup by Application:
- Bacterial Infection
- Fungal Infection
- Mycobacterial Infection
Breakup by End-User:
- Hospital Laboratories
- Reference Laboratories
- Research Laboratories
Market Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
If you want latest primary and secondary data (2021-2026) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: [email protected]
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800